« Back
Home /
TNF-RECEPTOR II (p75/p80)

TNF-RECEPTOR II (p75/p80)

Item no.	20-321-175021
Manufacturer	GENWAY
Amount	0.05 mg
Category	Metabolism Diabetes Antibodies Cell Biology Obesity Cell Status Necrosis Apoptosis Primary Antibodies
Type	Antibody
Clone	HM102
Specific against	other
ECLASS 5.1	32160702
ECLASS 6.1	32160702
ECLASS 8.0	32160702
ECLASS 9.0	32160702
ECLASS 10.0.1	32160702
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	GWB-58AA31
Similar products	20-321-175021
Available
Genway ID:	GWB-58AA31
Clone:	HM102
Applications:	The monoclonal antibody HM102 is an agonistic antibody and can be used for cell culture experiments and for flow cytometry. Furthermore the antibody HM102 is useful for immuno assays. immunoprecipitation and histology on frozen sections. The reactivity of the antibody with soluble TNF-Receptor is not inhibited by high concentrations of mouse TNF-alpha. The monoclonal antibody HM102 reacts with the extra-cellular part of the mouse TNF-RII and with the soluble receptor. TNF-RII is present on most cell types and is considered to play a prominent role in cell stimulation by TNF-alpha. The TNF-RII molecule is shown to be responsible for stimulation of activated T-lymphocytes by TNF-alpha.
Function:	Receptor with high affinity for TNFSF2/TNF-alpha and approximately 5-fold lower affinity for homotrimeric TNFSF1/lymphotoxin-alpha. The TRAF1/TRAF2 complex recruits the apoptotic suppressors BIRC2 and BIRC3 to TNFRSF1B/TNFR2. This receptor mediates most of the metabolic effects of TNF-alpha. Isoform 2 blocks TNF-alpha-induced apoptosis which suggests that it regulates TNF-alpha function by antagonizing its biological activity.
Subunit:	Binds to TRAF2.
Subcellular Location:	Isoform 1: Cell membrane; Single-pass type I membrane protein.
Subcellular Location:	Isoform 2: Secreted.
Subcellular Location:	Tumor necrosis factor-binding protein 2: Secreted.
Ptm:	Phosphorylated; mainly on serine residues and with a very low level on threonine residues.
Ptm:	A soluble form (tumor necrosis factor binding protein 2) is produced from the membrane form by proteolytic processing. Pharmaceutical: Available under the name Enbrel (Immunex and Wyeth-Ayerst). Used to treat moderate to severe rheumatoid arthritis (RA). Enbrel consist of the extracellular ligand-binding portion of TNFRSF1B linked to an immunoglobulin Fc chain. It binds to TNF-alpha and blocks its interactions with receptors.
Similarity:	Contains 4 TNFR-Cys repeats.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.05 mg

available

Delivery expected until 8/9/2024

Express Delivery: Save 2 days

Compare

Add to wishlist

Recommend by mail